Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Extension of Studies ATH-1017-AD-0201 and ATH-1017-AD-0202 in Subjects With Mild to Moderate Alzheimer's Disease

NCT04886063 is registered in ClinicalTrials.gov with LeonaBio as lead sponsor.

NCT NCT04886063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04886063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Extension of Studies ATH-1017-AD-0201 and ATH-1017-AD-0202 in Subjects With Mild to Moderate Alzheimer's Disease
Lead sponsor
LeonaBio
Phase
Phase 2/3
Overall status
Terminated
Start date
June 30, 2021
Completion date
October 23, 2024
Enrollment
423 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease